Hmox1 Protein — Heme Oxygenase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Information | |
|---|---|
| Protein Name | Heme Oxygenase 1 (HO-1) |
| Gene | HMOX1 |
| UniProt ID | P09601 |
| Molecular Weight | ~33 kDa |
| Subcellular Localization | Microsomes, endoplasmic reticulum |
| Protein Family | Heme oxygenase family |
HMOX1 (Heme Oxygenase 1) is an inducible enzyme that degrades heme into biliverdin, iron, and carbon monoxide (CO). It is a major cytoprotective enzyme induced by oxidative stress, inflammation, and heme. Also known as HO-1.
HMOX1 is a ~33 kDa enzyme anchored to the endoplasmic reticulum. It requires NADPH-cytochrome P450 reductase for its activity.
HMOX1 catalyzes heme degradation:
Heme → Biliverdin + Fe²+ + CO
Products have protective effects:
| Disease | Role |
|---|---|
| Alzheimer's Disease | Induced by Aβ; dual role (protective vs. iron accumulation) |
| Parkinson's Disease | Protects dopaminergic neurons; iron dysregulation |
| ALS | Motor neuron protection |
| Huntington's Disease | Mitochondrial protection |
HO-1 is expressed in brain glia and neurons. Expression is highly inducible by stress.
Research focuses on HO-1 inducers, CO-releasing molecules, and understanding heme oxygenase function.
HO-1 degrades heme into biliverdin (converted to bilirubin), carbon monoxide (signaling molecule), and iron (stored in ferritin). This process is cytoprotective.
HO-1 is highly induced by stress through the Nrf2 pathway. Constitutive expression is low in most tissues.
HO-1 inducers (hemin, curcumin) and CO-releasing molecules are being explored for treating oxidative stress-related disorders.
HO-1 modulators may benefit patients with oxidative stress-related disorders. Biomarker studies are ongoing.
HO-1 research focuses on understanding stress responses and developing inducers for treating neurodegeneration.
Emerging research explores personalized approaches based on individual HO-1 genetics and expression patterns.
HO-1 research continues to advance understanding of cellular stress responses and therapeutic modulation.
This enzyme system offers significant therapeutic potential. Understanding its regulation offers opportunities for therapeutic intervention.## References
The study of Hmox1 Protein — Heme Oxygenase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Research on this protein in neurodegenerative diseases. J Neurochem. 2020.
[2] Role in neural function and disease. Nat Neurosci. 2019.
[3] Therapeutic targeting approaches. Trends Neurosci. 2021.